𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amyloidosis in behçet's syndrome

✍ Scribed by Sebahattin Yurdakul; Nüket Tüzüner; Ibrahim Yurdakul; Vedat Hamuryudan; Hasan Yazici


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
350 KB
Volume
33
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


We investigated the frequency of amyloidosis in 99 consecutive patients (65 men and 34 women) with Behqet's syndrome. Rectal biopsies performed on all patients showed no amyloidosis by polarizing microscopy. The results of urinalyses were normal in all patients. Among 1,130 patients registered in our Behcet's syndrome outpatient clinic, 5 were found to have systemic amyloidosis, all of the AA type.

Although secondary amyloidosis is a well established complication in some chronic inflammatory disorders (e.g., rheumatoid arthritis and ankylosing spondylitis) (1,2), it seems to be infrequent in Behget's syndrome. The evidence for amyloidosis in Behget's syndrome is derived primarily from case reports or compiled series. A total of 24 patients with amyloidosis were reviewed recently (3). In a previous survey, we found no amyloidosis among 30 consecutive patients with BehCet's syndrome (4). In the present study, we expanded our survey to 99 patients (65 men and 34 women). In addition, we reviewed the medical records of 1,130 outpatients at our multdisiciplinary From the Departments of Medicine (


📜 SIMILAR VOLUMES


Pseudopodagra in Behçet' syndrome
✍ Alessandro Giacomellod; Maria Laura Sorgi; Antonio Zoppini 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB
Current management of Behçet's syndrome
✍ Johannes Nowatzky; Yusuf Yazici 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract Behçet's syndrome (BS), or Behçet's disease (BD), is a multisystem inflammatory disorder that mainly affects population clusters along the Old Silk Road; however, it has been reported worldwide. The disease is currently classified as a vasculitis, characterized by sporadic outbreaks. Th

Mortality in Behçet's disease
✍ D. Saadoun; B. Wechsler; K. Desseaux; D. Le Thi Huong; Z. Amoura; M. Resche-Rigo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views
Myositis in behçet's disease
✍ Vincenzo Di Giacomo; Giuseppe Carmenini; Fortunato Meloni; Guido Valesini 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views
A double-blind trial of colchicine in Be
✍ Sebahattin Yurdakul; Cem Mat; Yalçin Tüzün; Yilmaz Özyazgan; Vedat Hamuryudan; Ö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Objective. Colchicine is a widely used treatment for Behc ¸et's syndrome, even though in a previous 6-month controlled study, it was shown to be effective only in controlling erythema nodosum and arthralgias. We reassessed the effect of colchicine in Behc ¸et's syndrome in a study conducted among a